News

Special to Ophthalmology Times®

Tool for quantifying measures may predict outcomes for patients.

Substantial weight loss can help patients’ eye health, study results show.

The Research to Prevent Blindness (RPB), the Association of University Professors of Ophthalmology (AUPO) and an anonymous donor have recognized Donald Zack, MD, PhD, for ground-breaking contributions to the field of vision research.

According to Oculus, its Myopia Master saves space and can be mounted on a workstation or an ophthalmic table. The software is operated directly via an inbuilt display.

The company is evaluating topical cyclosporine to treat the signs and symptoms of dry eye disease.

According to the Refractive Surgery Council, patients continue to have a high level of interest in laser vision correction procedures.

pVerify's Vision Benefits API allows front-office staff to handle vision eligibility verifications seamlessly in their own EHR.

Most patients with allergic disorder are children, adolescents, or young adults.

Llama nanobodies may be key to beating COVID-19 variants.

The Glaucoma Research Foundation and the Refractive Surgery Council are welcomed as the two newest partners of the platform.

The Glaucoma Research Foundation and the Refractive Surgery Council are welcomed as the two newest partners of the platform.

A word from Chief Medical Editor Peter J. McDonnell, MD.

Heru Inc., announced Thursday that it has partnered with Vision Source on the commercial availability launch of re:Vive, a wearable diagnostics and visual field application.

Region may have world’s highest rate, investigators say.

Investigators from various companies described their diagnostic offerings at the Glaucoma Research Foundation’s 2021 New Horizons Forum.

Outlook Therapeutics has reported positive efficacy and safety data from Phase 3 NORSE TWO trial of bevacizumab-vikg.

Clinical trials show subretinal agents are safe, well tolerated by patients.

Focus on maximizing visual examination by combining methods of detection-based testing.

Option detects treatment-naive nonexudative macular neovascularization in eyes with dry age-related macular degeneration

The organization hopes to help 1 billion people worldwide, committing the international community to improve vision for 1.1 billion people living with preventable vision loss by 2030.

Telemedicine provides readiness in time of crisis.

The study's finding suggest that the particles may be involved in some of the ocular clinical manifestations of the COVID-19 infection.

Perhaps the most important consideration is understanding the neuromuscular pathway that retracts and protracts the eyelid.

As soon as 2 weeks after treatment, changes occur to foveal layer.

Use of a drug to correct the eyelid position could eliminate the complications associated with surgery.